REVISION 15 HIGHLIGHTS

This update of Dr. David Morton's Medical Issues in Social Security Disability updates his invaluable practice advice and forms. It includes:

New

• Discussion of changing ILAE classifications of epilepsy and a new table listing the classification of seizure types, §11.02.1.a
• Discussion of dysglycemia and its negative impact on neurocognitive function, §12.02.2
• Discussion of chemobrain, §13.02.3
• Discussion regarding no limitations for early prostate cancer even if unoperated and that such cancer has a prognosis no different than with surgery but without the adverse events, §13.24.2.
• Explanation of Ankylosing Spondylitis Disease Activity Score (ASDAS), §14.09.1.a

Updated

• Discussion of the efficacy of saline or steroid injections for the treatment of knee pain, §1.02.2
• Discussion of amputations related to diabetes mellitus, §1.05.2
• Discussion of transcatheter aortic valve replacement (TAVR) in relation to cerebral microbleeds, §4.02.3
• Discussion of coronary artery calcium (CAC) to assess chest pain in relation to ischemic heart disease, §4.04.1.a
• Discussion of Arizona University compendium of physical activities, METs required, with a discussion on why such information must be considered approximate, §4.04.a.1.
• Discussion of coronary bioabsorbable stent thrombosis compared to metal stents, and discussion of the SYNTAX score for coronary arterial disease, §4.04.3
• Discussion of the meaning of TASC classification of peripheral arterial lesions and its relevance to the adjudication of functional severity, §4.12.1.a
• Discussion of non-alcoholic fatty liver disease (NAFLD) and its association with many other types of disorders, §5.05.3
• Discussion of the probable cause of atopic dermatitis as the lack of "filament aggregating protein" (filaggrin) in the skin, §8.05.1.a
• Discussion of serious comorbidities that can be associated with having psoriasis, §8.05.3
• Added definitions for hyperkinetic activity and cognitive, §11.02.1.a
• Discussion of video EEG (vEEG) as the "gold standard" for evaluating pseudoseizures, §11.02.1.a
• Expanded discussion of Alzheimer's disease to include discussion of early diagnostic testing, progressive memory loss in relation to Alzheimer's, and treatments for mild to moderate Alzheimer's, §12.02.1.a
• Discussion of the importance of the SSA to evaluate the physical health of individuals with schizophrenia, since they have a premature mortality due to physical problems like diabetes, §12.03.2
• Updated state of knowledge about bipolar abnormalities on brain imaging, §12.04.1.a
• Updated information on the cause of autism and brain mapping in young infants, §12.10.1.a

With this new edition, Dr. David Morton's Medical Issues in Social Security Disability will continue to help you obtain persuasive medical source statements, provide medical data persuasive to SSA, and answer the medical questions arising in your daily work.